Research Article
Prognostic Factors of Radiofrequency Ablation plus Systemic Chemotherapy for Unresectable Colorectal Cancer with Liver Metastasis
Table 1
Baseline characteristics of study participants (
).
| Variables | (%) |
| Male | 49 (80.3) | Mean age (years) | (27-75) | ECOG | | 0 | 25 (41) | 1 | 36 (59) | Primary cancer | | Colon | 24 (39.3) | Rectum | 37 (60.7) | Type of metastasis | | Synchronous | 24 (39.3) | Metachronous | 37 (60.7) | Adjuvant chemotherapy for primary cancer | | Yes | 29 (47.5) | No | 32 (52.5) | Number of liver metastatic tumors | 166 (/patient) | 1–3 | 41 (67.2) | 4–5 | 20 (32.8) | Size of the largest liver lesion | | ≤3 cm | 21 (34.4) | > 3 cm | 40 (65.6) | Sum of lesion diameters | † | <5 cm | 26 (42.6) | 5–10 cm | 21 (34.4) | >10 cm | 14 (23.0) | Serum CEA | | ≤30 ng/mL | 40 (65.6) | >30 ng/mL | 21 (34.4) |
|
|
ECOG: Eastern Cooperative Oncology Group. Total number of liver metastatic lesions. †Mean sum of tumor diameters in a patient. |